A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer
NCT01784107
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Small Cell Lung Cancer
Interventions
DRUG:
Belotecan and Ifosfamide
Sponsor
Gachon University Gil Medical Center